| Plasticity in binding confers selectivity in ligand-induced protein degradation RP Nowak, SL DeAngelo, D Buckley, Z He, KA Donovan, J An, N Safaee, ... Nature chemical biology 14 (7), 706-714, 2018 | 521 | 2018 |
| Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration F Fan, Z He, LL Kong, Q Chen, Q Yuan, S Zhang, J Ye, H Liu, X Sun, ... Science translational medicine 8 (352), 352ra108-352ra108, 2016 | 369 | 2016 |
| A quantitative tissue-specific landscape of protein redox regulation during aging H Xiao, MP Jedrychowski, DK Schweppe, EL Huttlin, Q Yu, DE Heppner, ... Cell 180 (5), 968-983. e24, 2020 | 317 | 2020 |
| Light-induced control of protein destruction by opto-PROTAC J Liu, H Chen, L Ma, Z He, D Wang, Y Liu, Q Lin, T Zhang, N Gray, ... Science advances 6 (8), eaay5154, 2020 | 287 | 2020 |
| CDK7 inhibition potentiates genome instability triggering anti-tumor immunity in small cell lung cancer H Zhang, CL Christensen, R Dries, MG Oser, J Deng, B Diskin, F Li, Y Pan, ... Cancer cell 37 (1), 37-54. e9, 2020 | 192 | 2020 |
| Selective degradation of GSPT1 by cereblon modulators identified via a focused combinatorial library CE Powell, G Du, J Che, Z He, KA Donovan, H Yue, ES Wang, RP Nowak, ... ACS chemical biology 15 (10), 2722-2730, 2020 | 69 | 2020 |
| Development of CDK2 and CDK5 dual degrader TMX‐2172 M Teng, J Jiang, Z He, NP Kwiatkowski, KA Donovan, CE Mills, C Victor, ... Angewandte Chemie 132 (33), 13969-13974, 2020 | 61 | 2020 |
| Exploring the target scope of KEAP1 E3 ligase-based PROTACs G Du, J Jiang, NJ Henning, N Safaee, E Koide, RP Nowak, KA Donovan, ... Cell chemical biology 29 (10), 1470-1481. e31, 2022 | 55 | 2022 |
| Discovery and Identification of Small Molecules as Methuosis Inducers with in Vivo Antitumor Activities W Huang, X Sun, Y Li, Z He, L Li, Z Deng, X Huang, S Han, T Zhang, ... Journal of medicinal chemistry 61 (12), 5424-5434, 2018 | 48 | 2018 |
| Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling M Fan, W Lu, J Che, NP Kwiatkowski, Y Gao, HS Seo, SB Ficarro, ... Elife 11, e78810, 2022 | 46 | 2022 |
| Discovery of MFH290: a potent and highly selective covalent inhibitor for cyclin-dependent kinase 12/13 Y Liu, M Hao, AL Leggett, Y Gao, SB Ficarro, J Che, Z He, CM Olson, ... Journal of Medicinal Chemistry 63 (13), 6708-6726, 2020 | 36 | 2020 |
| Targeting BRK-positive breast cancers with small-molecule kinase inhibitors J Jiang, F Gui, Z He, L Li, Y Li, S Li, X Wu, Z Deng, X Sun, X Huang, ... Cancer research 77 (1), 175-186, 2017 | 29 | 2017 |
| A non‐covalent inhibitor XMU‐MP‐3 overrides ibrutinib‐resistant BtkC481S mutation in B‐cell malignancies F Gui, J Jiang, Z He, L Li, Y Li, Z Deng, Y Lu, X Wu, G Chen, J Su, S Song, ... British Journal of Pharmacology 176 (23), 4491-4509, 2019 | 21 | 2019 |
| Selective degradation-inducing probes for studying cereblon (CRBN) biology CE Powell, G Du, JW Bushman, Z He, T Zhang, ES Fischer, NS Gray RSC Medicinal Chemistry 12 (8), 1381-1390, 2021 | 20 | 2021 |
| Development of a covalent inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1 W Lu, Y Liu, Y Gao, Q Geng, D Gurbani, L Li, SB Ficarro, CJ Meyer, ... Journal of Medicinal Chemistry 66 (5), 3356-3371, 2023 | 13 | 2023 |
| Discovery of covalent MKK4/7 dual inhibitor J Jiang, B Jiang, Z He, SB Ficarro, J Che, JA Marto, Y Gao, T Zhang, ... Cell Chemical Biology 27 (12), 1553-1560. e8, 2020 | 13 | 2020 |
| Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism HY Liu, Z Li, T Reindl, Z He, X Qiu, RP Golden, KA Donovan, A Bailey, ... Nature Communications 15 (1), 5179, 2024 | 3 | 2024 |
| New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation ML Arwood, Y Liu, SK Harkins, DM Weinstock, L Yang, KE Stevenson, ... Cell chemical biology 30 (6), 618-631. e12, 2023 | 3 | 2023 |
| Imidazopyridine derivatives and aza-imidazopyridine derivatives as janus kinase 2 inhibitors and uses thereof NS Gray, T Zhang, Y Liu, Z He, M Hao, D Weinstock, LSM Li US Patent App. 17/291,927, 2022 | 3 | 2022 |
| Inhibitors of cyclin-dependent kinase 7 and uses thereof NS Gray, T Zhang, NP Kwiatkowski, J Jiang, M Hao, Z He US Patent App. 17/418,353, 2022 | 3 | 2022 |